Moving beyond energy homeostasis: New roles for glucagon-like peptide-1 in food and drug reward
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide-1 (GLP-1), a hormone and neuropeptide, is known to regulate energy homeostasis in part through an established central role in controlling food intake. Historically this central role has largely been attributed to GLP-1 receptor signaling in the brainstem and hypothalamus. However, emerging data indicate that GLP-1 also contributes to non-homeostatic regulation of food reward and motivated behaviors in brain reward centers, including the ventral tegmental area and nucleus accumbens. The hypothesis that GLP-1 signaling modulates reward circuitry has provided the impetus for studies demonstrating that GLP-1 attenuates reward for psychostimulants and alcohol. Here, we examine current evidence for GLP-1-mediated regulation of food and drug reward and use these findings to hypothesize mechanisms of action within brain reward centers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Dissecting components of reward: ‘liking’, ‘wanting’, and learning
Berridge, K. C., Robinson, T. E., & Aldridge, J. W. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.014 · Cited by 1,942
Wang, G.-J., Volkow, N. D., Logan, J., Pappas, N. R., Wong, C. T., Zhu, W., Netusll, N., & Fowler, J. S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03643-6 · Cited by 1,864 · cited 5×
“, 2008), which may be related to a lower availability of D2 DA receptors within the striatum (Wang et al., 2001).”
InfluentialRapid regulation of depression-related behaviours by control of midbrain dopamine neurons
Chaudhury, D., Walsh, J. J., Friedman, A. K., Juarez, B., Ku, S. M., Koo, J. W., Ferguson, D., Tsai, H.-C., Pomeranz, L., Christoffel, D. J., et al. (2013) · Nature · doi:10.1038/nature11713 · Cited by 1,156 · cited 1×
“Food restriction promotes drug intake in humans (Hall et al., 1992) and provokes relapse to heroin and cocaine in animal self-administration models (Carroll, 1985; Comer et al., 1995; eostasis: New roles for glucagon-like peptide-1 in food and drug reward.”
How can drug addiction help us understand obesity?
Volkow, N. D., & Wise, R. A. (2005) · Nature Neuroscience · doi:10.1038/nn1452 · Cited by 1,089 · cited 2×
“obese and drug-dependent subjects (Volkow and Wise, 2005; Wang et al., 2001).”
Imaging dopamine's role in drug abuse and addiction
Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., & Telang, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.022 · Cited by 988
Vilsboll, T., Christensen, M., Junker, A. E., Knop, F. K., & Gluud, L. L. (2012) · BMJ · doi:10.1136/bmj.d7771 · Cited by 970 · cited 2×
“ulation with minimal side effects (Vilsboll et al., 2012).”
Leptin Receptor Signaling in Midbrain Dopamine Neurons Regulates Feeding
Hommel, J. D., Trinko, R., Sears, R. M., Georgescu, D., Liu, Z.-W., Gao, X.-B., Thurmon, J. J., Marinelli, M., & DiLeone, R. J. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.023 · Cited by 902
Neurobiology of relapse to heroin and cocaine seeking: a review
Shalev, U., Grimm, J. W., & Shaham, Y. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.1 · Cited by 880
Widespread reward-system activation in obese women in response to pictures of high-calorie foods
Stoeckel, L. E., Weller, R. E., Cook, E. W., Twieg, D. B., Knowlton, R. C., & Cox, J. E. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.02.031 · Cited by 857 · cited 1×
“Obese subjects, when compared with normal-weight subjects, show increased activation of certain brain reward centers in response to caloriedense food cues (Stoeckel et al., 2008).”
Stice, E., Spoor, S., Bohon, C., Veldhuizen, M. G., & Small, D. M. (2008) · Journal of Abnormal Psychology · doi:10.1037/a0013600 · Cited by 779 · cited 2×
“At the same time, obese individuals exhibit decreased activation of the caudate nucleus in response to consumption of a palatable milkshake (Stice et al., 2008), which may be related to a lower availability of D2 DA receptors within the striatum (Wang et al., 2001).”
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass
le Roux, C. W., Welbourn, R., Werling, M., Osborne, A., Kokkinos, A., Laurenius, A., Lönroth, H., Fändriks, L., Ghatei, M. A., Bloom, S. R., et al. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e3180caa3e3 · Cited by 741 · cited 1×
“In support of this notion, RYGB ‘‘good responders’’ ( 40% weight loss) secreted significantly more GLP-1 in response to a post-operative test meal than ‘‘poor responders’’ (<20% weight loss) (le Roux et al., 2007; Moran and Dailey, 2011).”
Dopaminergic Network Differences in Human Impulsivity
Buckholtz, J. W., Treadway, M. T., Cowan, R. L., Woodward, N. D., Li, R., Ansari, M. S., Baldwin, R. M., Schwartzman, A. N., Shelby, E. S., Smith, C. E., et al. (2010) · Science · doi:10.1126/science.1185778 · Cited by 600 · cited 1×
“This finding is striking as it illuminates the intrinsic challenges to overcoming reward-seeking behavior in vulnerable individuals (Buckholtz et al., 2010; Flagel et al., 2010).”
Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats
Tang-Christensen, M., Larsen, P. J., Goke, R., Fink-Jensen, A., Jessop, D. S., Moller, M., & Sheikh, S. P. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.4.r848 · Cited by 597
Food and Drug Reward: Overlapping Circuits in Human Obesity and Addiction
Volkow, N. D., Wang, G. J., Fowler, J. S., Tomasi, D., & Baler, R. (2011) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2011_169 · Cited by 525
Alhadeff, A. L., Rupprecht, L. E., & Hayes, M. R. (2012) · Endocrinology · doi:10.1210/en.2011-1443 · Cited by 515 · cited 12×
“In one study, injection of subthreshold doses of Ex-4 into the VTA or NAc core, but not the NAc shell, of food-deprived rats resulted in a significant suppression of sucrose intake at multiple time points compared to vehicle-injected animals (Alhadeff et al., 2012).”
InfluentialFiglewicz, D. P., Evans, S. B., Murphy, J., Hoen, M., & Baskin, D. G. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04087-8 · Cited by 482
Göke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474 · cited 4×
“The GLP-1 receptor appears to be expressed both in the VTA and the NAc based upon studies of GLP-1 immunoreactivity, autoradiographic binding, in situ hybridization, and direct neural tracing between these areas and the NTS (Alhadeff et al., 2012; Dossat et al., 2011; Göke et al., 1995; Gu et al., 2013; Merchenthaler…”
InfluentialVolkow, N. D., Wang, G., Fowler, J. S., Logan, J., Jayne, M., Franceschi, D., Wong, C., Gatley, S. J., Gifford, A. N., Ding, Y., et al. (2002) · Synapse · doi:10.1002/syn.10075 · Cited by 452 · cited 1×
“In particular, increases in extracellular DA appear to be associated with desire for palatable foods (Volkow et al., 2002).”
Dickson, S. L., Shirazi, R. H., Hansson, C., Bergquist, F., Nissbrandt, H., & Skibicka, K. P. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6326-11.2012 · Cited by 414 · cited 14×
“Finally, Ex-4 injected into the VTA, but not the NAc shell, reduced 24 h chow intake, and the activation of GLP-1 receptors in the VTA maintained a significant reduction in food intake even 24 h after injection (Dickson et al., 2012).”
InfluentialCommon cellular and molecular mechanisms in obesity and drug addiction
Kenny, P. J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3105 · Cited by 382
Kanoski, S. E., Fortin, S. M., Arnold, M., Grill, H. J., & Hayes, M. R. (2011) · Endocrinology · doi:10.1210/en.2011-0174 · Cited by 347 · cited 3×
“It is also possible that endogenous GLP-1 or its long-lasting analogues are influencing central signaling through vagal transmission (Abbott et al., 2005; Kakei et al., 2002; Kanoski et al., 2011; Rinaman, 2010; Williams, 2009).”
Flagel, S. B., Robinson, T. E., Clark, J. J., Clinton, S. M., Watson, S. J., Seeman, P., Phillips, P. E. M., & Akil, H. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.142 · Cited by 339 · cited 1×
“This finding is striking as it illuminates the intrinsic challenges to overcoming reward-seeking behavior in vulnerable individuals (Buckholtz et al., 2010; Flagel et al., 2010).”
The vagus nerve, food intake and obesity
Berthoud, H.-R. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2007.08.024 · Cited by 316
Rinaman, L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.059 · Cited by 311 · cited 5×
“GLP-1 is also a neuropeptide produced by brainstem neurons in the nucleus of the tractus solitarius (NTS) which project widely to subcortical areas containing the GLP-1 receptor (Merchenthaler et al., 1999; Rinaman, 2010).”
InfluentialAdiposity signals and food reward: expanding the CNS roles of insulin and leptin
Figlewicz, D. P. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00602.2002 · Cited by 221 · cited 1×
“Knowing that food restriction reduces plasma levels of the anorexigenic hormones leptin and insulin and that both express receptors in brain reward centers (Figlewicz, 2003; Figlewicz et al., 2003), investigators hypothesized that replacement of these hormones could rescue potentiated reward.”
Alterations of Central Dopamine Receptors Before and After Gastric Bypass Surgery
Steele, K. E., Prokopowicz, G. P., Schweitzer, M. A., Magunsuon, T. H., Lidor, A. O., Kuwabawa, H., Kumar, A., Brasic, J., & Wong, D. F. (2010) · Obesity Surgery · doi:10.1007/s11695-009-0015-4 · Cited by 213
The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents
Egecioglu, E., Steensland, P., Fredriksson, I., Feltmann, K., Engel, J. A., & Jerlhag, E. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.11.009 · Cited by 207 · cited 9×
“We know from the animal behavioral studies presented here that Ex-4 attenuates the pharmacological effects of psychostimulants and alcohol (Egecioglu et al., 2013a,b; Erreger et al., 2012), reduces the rewarding properties of psychostimulants and alcohol (Egecioglu et al., 2013a,b; Graham et al.,…”
InfluentialOn the physiology of GIP and GLP-1
Holst, J. J. (2004) · Hormone and Metabolic Research · doi:10.1055/s-2004-826158 · Cited by 189 · cited 1×
“Thus, earlier research focused on the effects of GLP-1 on the hypothalamus and brainstem, regions highly involved in homeostatic metabolic control (Baggio and Drucker, 2007; Holst, 2004).”
Decreased Dopamine Type 2 Receptor Availability After Bariatric Surgery: Preliminary Findings
Dunn, J. P., Cowan, R. L., Volkow, N. D., Feurer, I. D., Li, R., Williams, D. B., Kessler, R. M., & Abumrad, N. N. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.064 · Cited by 151 · cited 1×
“PET studies have also revealed alterations in D2 DA receptor availability and extracellular DA following RYGB (Dunn et al., 2010; Steele et al., 2010).”
Gastric bypass surgery attenuates ethanol consumption in ethanol-preferring rats
Davis, J. F., Schurdak, J. D., Magrisso, I. J., Mul, J. D., Grayson, B. E., Pfluger, P. T., Tschöp, M. H., Seeley, R. J., & Benoit, S. C. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.01.035 · Cited by 81
Cited by
The dopamine motive system: implications for drug and food addiction
Volkow, N. D., Wise, R. A., & Baler, R. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.130 · Cited by 939
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Klausen, M. K., Thomsen, M., Wortwein, G., & Fink‐Jensen, A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15677 · Cited by 259
“…for new treatments of AUD (Lyon, 2017), nicotine use disorder (Polosa & Benowitz, 2011) and SUD (Klein, 2016), the gut hormone glucagon-like peptide 1 (GLP-1) has received much attention (Eren-Yazicioglu et al., 2021; Fink-Jensen & Vilsbøll, 2016; Jerlhag, 2020; Reddy et al., 2014; Skibicka, 2013).”
Backgroundvan Bloemendaal, L., Veltman, D. J., ten Kulve, J. S., Groot, P. F. C., Ruhé, H. G., Barkhof, F., Sloan, J. H., Diamant, M., & Ijzerman, R. G. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12506 · Cited by 151
Sørensen, G., Reddy, I. A., Weikop, P., Graham, D. L., Stanwood, G. D., Wortwein, G., Galli, A., & Fink-Jensen, A. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.06.013 · Cited by 140
Self-citationReddy, I. A., Pino, J. A., Weikop, P., Osses, N., Sørensen, G., Bering, T., Valle, C., Bluett, R. J., Erreger, K., Wortwein, G., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.86 · Cited by 96
Self-citation
Metadata
- Authors
- Reddy, I. A., Stanwood, G. D., & Galli, A.
- Venue
- Neurochemistry International
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 73
- Pages
- 49-55
- ISSN
- 0197-0186 (ISSN-L)
- OpenAlex
- W1999164201
- Cited by
- 35
- References
- 31
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.